Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor ...

AI-powered tools like Merck’s Aiddison can accelerate drug identification and optimise design, cutting both costs and time to ...

Hyderabad: US pharma giant Merck & Co Inc, which does business as Merck Sharp & Dohme (MSD) outside the United States and Canada, opened its first tec.

Drugmaker Merck , known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India sites by ...

In a regulatory filing, the Mumbai-based drug maker said that in 2023 it had settled with three plaintiff groups referred as ...

The lawsuits were antitrust and consumer protection claims, including a class action, and were consolidated in Virginia, US.

Glenmark Pharmaceuticals rose 2.71% to Rs 1335.50 after the company reached a settlement agreement with three plaintiffs, Humana Inc., Centene Corporation, and Kaiser Foundation Health Plan, Inc., for ...

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...

It's been a rough start to 2025 for Merck (NYSE: MRK) shareholders following a less-than-stellar fourth-quarter earnings report. Even as the pharmaceutical giant exceeded Wall Street estimates ...

Lawsuits surrounding Merck's HPV vaccine Gardasil have been piling up for years now, but they've garnered increased public attention lately after HHS Secretary Robert F. Kennedy Jr.'s links to the ...

Merck & Co.’s first trial over the safety of its blockbuster Gardasil cancer vaccine was cut short and rescheduled amid concerns that jurors might be influenced by controversy this month around ...